What is Allyx Therapeutics worth?
$32.3Mlast known valuation
Allyx Therapeutics last raised $26.4M in its Early Stage VC (May 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Allyx Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Early Stage VC | $26.4M | ▮ | ▮ |
| Feb 2026 | Seed Round | $3.3M | ▮ | ▮ |
| Feb 2023 | Seed Round | $2.3M | ▮ | ▮ |
| May 2021 | Early Stage VC | $7.6M | ▮ | ▮ |
How Allyx Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Allyx Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Allyx Therapeutics worth?
- Allyx Therapeutics's last known valuation is $32.3M.
- How much has Allyx Therapeutics raised?
- Allyx Therapeutics has raised $13.2M in total funding across 4 recorded rounds.
- When did Allyx Therapeutics last raise?
- Allyx Therapeutics last raised in May 2026 (Early Stage VC), raising $26.4M.